Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

Background: Behçet's disease is a multisystem vasculitis of unknown origin. Standard treatment mainly comprises systemic immunosuppressive agents. Ocular involvement, mostly posterior uveitis with retinal vasculitis, leads to blindness in 20–50% of the involved eyes within 5 years. The efficacy...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kötter, I, Zierhut, M, Eckstein, A K, Vonthein, R, Ness, T, Günaydin, I, Grimbacher, B, Blaschke, S, Meyer-Riemann, W, Peter, H H, Stübiger, N
Format: Artigo
Jezik:Inglês
Izdano: Copyright 2003 British Journal of Ophthalmology 2003
Teme:
Clinical Science
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1771623/
https://ncbi.nlm.nih.gov/pubmed/12642304
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki